This study investigates the effect of fractionated (two-part) PDT on the long-term local control rate (LCR) using the concentration of reactive oxygen species ([ROS]) as a dosimetry quantity. Groups with different fractionation schemes are examined, including a 2 h interval between light delivery sessions to cumulative fluences of 135, 180, and 225 J/cm. While the total treatment time remains constant within each group, the division of treatment time between the first and second fractionations are explored to assess the impact on long-term survival at 90 days. In all preclinical studies, Photofrin is intravenously administered to mice at a concentration of 5 mg/kg, with an incubation period between 18 and 24 h before the first light delivery session. Fluence rate is fixed at 75 mW/cm. Treatment ensues via a collimated laser beam, 1 cm in diameter, emitting light at 630 nm. Dosimetric quantities are assessed for all groups along with long-term (90 days) treatment outcomes. This study demonstrated a significant improvement in long-term survival after fractionated treatment schemes compared to single-fraction treatment, with the optimal 90-day survival increasing to 63%, 86%, and 100% vs. 20%, 25%, and 50%, respectively, for the three cumulative fluences. The threshold [ROS] for the optimal scheme of fractionated Photofrin-mediated PDT, set at 0.78 mM, is significantly lower than that for the single-fraction PDT, at 1.08 mM.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10705090 | PMC |
http://dx.doi.org/10.3390/cancers15235682 | DOI Listing |
Pediatr Qual Saf
January 2025
Division of Cardiology, Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Ga.
Acta Cardiol Sin
January 2025
Cardiovascular Center, Taichung Veterans General Hospital, Taichung.
Background: Atrial fibrillation (AF) increases the risks of stroke and mortality. It remains unclear whether rhythm control reduces the risk of stroke in patients with AF concomitant with hypertrophic cardiomyopathy (HCM).
Methods: We identified AF patients with HCM who were ≥ 18 years old in the Taiwan National Health Insurance Database.
Ecol Evol
January 2025
Département de Biologie, Chimie et Géographie Université du Québec à Rimouski Rimouski Quebec Canada.
This study presents the first movement analysis of snow leopards () using satellite telemetry data, focusing on the northeastern Himalayas of Nepal. By examining GPS-based satellite collar data between 2013 and 2017 from five collared snow leopards (effectively three individuals), the research uncovered distinct movement patterns, activity budgeting and home range utilisation from one adult male and two sub adult females. Hidden Markov models (HMMs) revealed three behavioural states based on the movement patterns-slow (indicative of resting), moderate and fast (associated with travelling) and demonstrated that the time of day influenced their behavioural state.
View Article and Find Full Text PDFEcol Evol
January 2025
Whale and Dolphin Conservation Adelaide South Australia Australia.
Understanding population demography of threatened species and how they vary in relation to natural and anthropogenic stressors is essential for effective conservation. We used a long-term photographic capture-recapture dataset (1993-2020) of Indo-Pacific bottlenose dolphins () in the highly urbanised Adelaide Dolphin Sanctuary (ADS), South Australia, to estimate key demographic parameters and their variability over time. These parameters were analysed in relation to environmental variables used as indicators of local and large-scale climatic events.
View Article and Find Full Text PDFNeurooncol Pract
February 2025
Department of Neurological Surgery, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.
The clinical efficacy of isocitrate dehydrogenase (IDH) inhibitors in the treatment of patients with grade 2 IDH-mutant (mIDH) gliomas is a significant therapeutic advancement in neuro-oncology. It expands treatment options beyond traditional radiation therapy and cytotoxic chemotherapy, which may lead to significant long-term neurotoxic effects while extending patient survival. The INDIGO study demonstrated that vorasidenib, a pan-mIDH inhibitor, improved progression-free survival for patients with grade 2 mIDH gliomas following surgical resection or biopsy compared to placebo and was well tolerated.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!